英文名稱 |
中文名稱 |
CAS號 |
操作 |
Insulin Receptor (1142-1153) |
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS-NH2 |
|
詳細(xì)
|
MARCKS PSD-Derived Peptide, PKC Substrate |
LYS-LYS-ARG-PHE-SER-PHE-LYS-LYS-SER-PHE-LYS-LEU |
|
詳細(xì)
|
C. difficile Toxin B (392-401) |
ASP-SER-TYR-CYS-SER-ASN-LEU-ILE-VAL-LYS |
|
詳細(xì)
|
CYT-1010 |
CYT-1010 |
213769-33-6 |
詳細(xì)
|
β-Endorphin,human |
β-Endorphin |
60617-12-1 |
詳細(xì)
|
Biotin-Parathyroid Hormone (1-34), human |
BIOTIN-SER-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE |
|
詳細(xì)
|
Pannexin-1 Fragment (4515) |
GLU-LYS-ASN-SER-ARG-GLN-ARG-LEU-LEU-ASN-PRO-SER |
|
詳細(xì)
|
Pro34]Peptide YY, PYY, human |
TYR-PRO-ILE-LYS-PRO-GLU-ALA-PRO-GLY-GLU-ASP-ALA-SER-PRO-GLU-GLU-LEU-ASN-ARG-TYR-TYR-ALA-SER-LEU-ARG-HIS-TYR-LEU-ASN-LEU-VAL-THR-ARG-PRO-ARG-TYR- NH2 |
|
詳細(xì)
|
Ile7] Angiotensin III |
(DES-ASP1,ILE8)-ANGIOTENSIN II |
52498-25-6 |
詳細(xì)
|
β II probe |
H-SER-SER-LEU-ASP-LEU-SER-GLN-PHE-PRO-MET-THR-ALA-SER-PHE-LEU-ARG-GLU-SER-ARG-OH |
|
詳細(xì)
|
CG-8-NH2 |
DES-GLY9-縮宮素 |
|
詳細(xì)
|
Kallikrein Inhibitor |
激肽釋放酶抑制劑 |
97145-43-2 |
詳細(xì)
|
Leu31,Pro34]-Peptide YY (human) |
(LEU31,PRO34)-PEPTIDE YY (HUMAN) |
|
詳細(xì)
|
Gln144]-PLP (139-151), Q144-PLP(139-151) |
HIS-SER-LEU-GLY-LYS-GLN-LEU-GLY-HIS-PRO-ASP-LYS-PHE |
|
詳細(xì)
|
Pannexin-1 Fragment (4512) |
VAL-GLN-GLN-LYS-SER-SER-LEU-GLN-SER-GLU-SER-GLY-ASN |
|
詳細(xì)
|
(Gln9)-Amyloid β-Protein (1-40) |
(Gln)-Amyloid β-Protein (1-40) |
1802084-59-8 |
詳細(xì)
|
Biotin-[Tyr0]-Orexin B, mouse, rat |
BIOTIN-TYR-ARG-PRO-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-ASN-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2 |
|
詳細(xì)
|
D-Ala2] Leu-Enkephalin, amide |
enkephalinamide-Leu, Ala(2)- |
65189-64-2 |
詳細(xì)
|
α-Conotoxin PIA |
A-CONOTOXIN PIA |
669050-68-4 |
詳細(xì)
|
β-Amyloid (10-35) |
AMYLOID BETA-PROTEIN (10-35) |
237753-66-1 |
詳細(xì)
|
ZIP (Scrambled) |
加擾控制肽 |
908012-18-0 |
詳細(xì)
|
β III probe |
H-SER-SER-GLU-ALA-CYS-VAL-GLY-ARG-TRP-MET-LEU-CYS-GLU-GLN-LEU-GLY-VAL-SER-ARG-OH |
|
詳細(xì)
|
IRBP (1-20), human |
IRBP (1-20), human |
298202-25-2 |
詳細(xì)
|
Orexin B,canine |
ARG-PRO-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2 |
|
詳細(xì)
|
Activity-Dependent Neurotrophic Factor, ADNF |
SER-ALA-LEU-LEU-ARG-SER-ILE-PRO-ALA |
|
詳細(xì)
|
[Ile8]-Oxytocin |
(ILE8)-OXYTOCIN |
|
詳細(xì)
|
abIII probe |
SER-SER-TRP-ASP-MET-HIS-GLN-PHE-PHE-TRP-GLU-GLY-VAL-SER-ARG |
|
詳細(xì)
|
Ala13]-Apelin-13 |
GLN-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-ALA |
568565-11-7 |
詳細(xì)
|
Lys15]-Amyloid β-Protein (15-21) |
Β淀粉樣肽改造多肽-[LYS15]-AMYLOID Β-PROTEIN (15-21) |
190775-14-5 |
詳細(xì)
|
Urocortin (human) |
人尿皮質(zhì)素 |
176591-49-4 |
詳細(xì)
|
Biotin-Obestatin (rat) |
BIOTIN-PHE-ASN-ALA-PRO-PHE-ASP-VAL-GLY-ILE-LYS-LEU-SER-GLY-ALA-GLN-TYR-GLN-GLN-HIS-GLY-ARG-ALA-LEU-NH2 |
|
詳細(xì)
|
Prolactin Releasing Peptide (12-31), bovine |
THR-PRO-ASP-ILE-ASN-PRO-ALA-TRP-TYR-ALA-GLY-ARG-GLY-ILE-ARG-PRO-VAL-GLY-ARG-PHE-NH2 |
|
詳細(xì)
|
DPDPE |
(Δ-OPIOID)受體激動劑多肽 |
88373-73-3 |
詳細(xì)
|
Parathyroid Hormone (1-34)-Lys(Biotin), human |
SER-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE-LYS(BIOTIN) |
|
詳細(xì)
|
Ile76]-TNF-a (70-80) (human) |
PRO-SER-THR-HIS-VAL-LEU-ILE-THR-HIS-THR-ILE |
|
詳細(xì)
|
Biotin-Insulin Receptor (1142-1153) |
BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS |
|
詳細(xì)
|
Biotin-Kinase Domain of Insulin Receptor (5) |
BIOTIN-THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-PTYR-PTYR-ARG-LYS |
|
詳細(xì)
|
C. difficile Toxin B (248-262) |
ASN-GLY-GLU-SER-PHE-ASN-LEU-TYR-GLU-GLN-GLU-LEU-VAL-GLU-ARG |
|
詳細(xì)
|
Kinase Domain of Insulin Receptor (1) |
TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS-GLY-GLY-LYS-GLY-LEU |
|
詳細(xì)
|
H-Met-Gly-Pro-pNA |
H-MET-GLY-PRO-PNA |
|
詳細(xì)
|
Tyr36]-pTH-Related Protein (1-36) (human, rat) |
(TYR36)-PTH-RELATED PROTEIN (1-36) (HUMAN, RAT) |
|
詳細(xì)
|
TNF-α(78-96) (human) |
H-HIS-THR-ILE-SER-ARG-ILE-ALA-VAL-SER-TYR-GLN-THR-LYS-VAL-ASN-LEU-LEU-SER-ALA-OH |
|
詳細(xì)
|
Ac-Gly-Pro-Lys(Ac)-pNA |
|
|
詳細(xì)
|
Ac-Ile-Glu-Gly-Arg-pNA |
|
|
詳細(xì)
|
C. difficile Toxin B (529-536) |
ALA-GLN-PHE-GLU-GLU-TYR-LYS-ARG |
|
詳細(xì)
|
SRC Kinase Substrate, amide |
ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY-NH2 |
|
詳細(xì)
|
Pyr-Gly-Arg-pNA |
PYR-GLY-ARG-PNA |
|
詳細(xì)
|
Saposin C22 |
CYS-GLU-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU |
|
詳細(xì)
|
Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC |
BOC-PHE-ALA-ALA-GLY-ARG-LYS-AMC |
|
詳細(xì)
|
Boc-Pro-Arg-Arg-AMC |
BOC-PRO-ARG-ARG-AMC |
|
詳細(xì)
|
PKG Substrate |
ARG-LYS-ARG-SER-ARG-ALA-GLU: RKRSRAE |
81187-14-6 |
詳細(xì)
|
Steroid Receptor Co - Factor Peptide |
LEU-THR-GLU-ARG-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-GLU |
|
詳細(xì)
|
SH2 Domain Ligand (4) |
AC-TYR(PO3H2)-TYR(PO3H2)-TYR(PO3H2)-ILE-GLU-OH |
159439-85-7 |
詳細(xì)
|
Salusin- β |
H-ALA-ILE-PHE-ILE-PHE-ILE-ARG-TRP-LEU-LEU-LYS-LEU-GLY-HIS-HIS-GLY-ARG-ALA-PRO-PRO-OH |
|
詳細(xì)
|
Biotin-Secretin,human |
BIOTIN-HIS-SER-ASP-GLY-THR-PHE-THR-SER-GLU-LEU-SER-ARG-LEU-ARG-GLU-GLY-ALA-ARG-LEU-GLN-ARG-LEU-LEU-GLN-GLY-LEU-VAL-NH2 |
|
詳細(xì)
|
Lamprey PQRFamide |
SER-TRP-GLY-ALA-PRO-ALA-GLU-LYS-PHE-TRP-MET-ARG-ALA-MET-PRO-GLN-ARG-PHE-NH2 |
|
詳細(xì)
|
P55-TNFR |
LEU-PRO-GLN-ILE-GLU-ASN-VAL-LYS-GLY-THR-GLU-ASP |
|
詳細(xì)
|
RF-amide peptide, Drosophila |
THR-ASP-VAL-ASP-HIS-VAL-PHE-LEU-ARG-PHE-NH2 |
|
詳細(xì)
|
Caspase 1 Substrate 1 (ICE), chromogenic |
AC-TYR-GLU-VAL-ASP-PNA |
|
詳細(xì)
|
FMRF-related peptide, SDPFLRF-NH2 |
|
|
詳細(xì)
|
Kinase Domain of Insulin Receptor (4) |
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-PTYR-ARG-LYS |
|
詳細(xì)
|
CC Chemokine Receptor 3 Fragment II |
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS |
|
詳細(xì)
|
Neurokinin Receptor (393-407), rat |
LYS-THR-MET-THR-GLU-SER-SER-PHE-TYR-SER-ASN-MET-LEU-ALA |
|
詳細(xì)
|
Tyr1]-pTH (1-34) (rat) |
(TYR1)-PTH (1-34) (RAT) |
|
詳細(xì)
|
Kinase Domain of Insulin Receptor (5) |
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-PTYR-PTYR-ARG-LYS |
|
詳細(xì)
|
D-Phe7, D-Trp10]-Somatostatin 14 (7-14) |
D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR (DISULFIDE BRIDGE: CYS2-CYS7) |
|
詳細(xì)
|
Ac-Ile-Glu-Ala-Arg-pNA |
AC-ILE-GLU-ALA-ARG-PNA |
|
詳細(xì)
|
CC Chemokine Receptor 3 Fragment I, amide |
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS-GLU-LYS-ALA-ASP-THR-ARG-NH2 |
|
詳細(xì)
|
N(p-Tosyl)-Gly-Pro-Arg-pNA |
N(P-TOSYL)-GLY-PRO-ARG-PNA |
|
詳細(xì)
|
C. difficile Toxin B (8-16) |
GLN-LEU-GLU-LYS-MET-ALA-ASN-VAL-ARG |
|
詳細(xì)
|
Kinase Domain of Insulin Receptor (2) |
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-TYR-TYR-ARG-LYS |
|
詳細(xì)
|
Nle8’18,Tyr34]-pTH (7-34) amide (bovine) |
(NLE8·18,TYR34)-PTH (7-34) AMIDE (BOVINE) |
|
詳細(xì)
|
Boc-Arg-Arg-Arg-AMC |
BOC-ARG-ARG-ARG-AMC |
|
詳細(xì)
|
TNF-α (72-82), human |
H-PRO-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-OH |
|
詳細(xì)
|
RSK Substrate, S6 (231-239) |
ARG-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA-NH2 |
|
詳細(xì)
|
Ac-Gly-Pro-Lys-pNA |
AC-GLY-PRO-LYS-PNA |
|
詳細(xì)
|
Tyr0]-pTH-Related Protein (1-34) (human, rat) |
(TYR0)-PTH-RELATED PROTEIN (1-34) (HUMAN, RAT) |
|
詳細(xì)
|
AT1A, Angiotensin II receptor, (225-237) |
ALA-TYR-GLU-ILE-GLN-LYS-ASN-LYS-PRO-ARG-ASN-ASP-ASP |
|
詳細(xì)
|
Human CMV Assemblin Protease Substrate (M-site) |
ARG-GLY-VAL-VAL-ASN-ALA-SER-SER-ARG-LEU-ALA-LYS |
|
詳細(xì)
|
MMP-3 Substrate I, fluorogenic |
DNP-PRO-TYR-ALA-TYR-TRP-MET-ARG |
|
詳細(xì)
|
Interleukin-6 Receptor (partial) |
THR-SER-LEU-PRO-VAL-GLN-ASP-SER-SER-SER-VAL-PRO |
|
詳細(xì)
|
Suc-Arg-Gly-Pro-Phe-pNA |
SUC-ARG-GLY-PRO-PHE-PNA |
|
詳細(xì)
|
Suc-Ser-Asp-Pro-Phe-pNA |
SUE-SER-ASP-PRO-PHE-PNA |
|
詳細(xì)
|
RF-amide, Chicken |
LEU-PRO-LEU-ARG-PHE-NH2: LPLRF-NH2 |
|
詳細(xì)
|
Biotin-Kinase Domain of Insulin Receptor (2) |
BIOTIN-THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-TYR-TYR-ARG-LYS |
|
詳細(xì)
|
Insulin Receptor (1142-1153), pTyr1150, Biotinylated |
BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS |
|
詳細(xì)
|
Angiotensin II Receptor, AT2, Amino Terminal Fragment |
MET-LYS-ASP-ASN-PHE-SER-PHE-ALA-ALA-THR-SER-ARG-ASN-ILE-THR-SER-SER |
|
詳細(xì)
|
MARCKS Substrate (151-175) |
LYS-LYS-LYS-LYS-LYS-ARG-PHE-PSER-PHE-LYS-LYS-PSER-PHE-LYS-LEU-SER-GLY-PHE-PSER-PHE-LYS-LYS-ASN-LYS-LYS |
|
詳細(xì)
|
GSK3 Peptide Substrate |
GLY-ARG-PRO-ARG-THR-THR-SER-PHE-ALA-GLU |
|
詳細(xì)
|
Vanilloid Receptor Subtype 1 (VR1) |
CYS-GLU-ASP-ALA-GLU-VAL-PHE-LYS-ASP-SER-MET-VAL-PRO-GLY-GLU-LYS |
|
詳細(xì)
|
MMP Biotinylated Substrate I |
BIOTIN-LC-PRO-LEU-GLY-LEU-ARG-ALA-TYR-NH2 |
|
詳細(xì)
|
D-Ser13]-Somatostatin-14 |
(D-SER13)-SOMATOSTATIN-14 |
|
詳細(xì)
|
(Asp)-pTH (39-84) (human) |
H-ALA-PRO-LEU-ALA-PRO-ARG-ASP-ALA-GLY-SER-GLN-ARG-PRO-ARG-LYS-LYS-GLU-ASP-ASN-VAL-LEU-VAL-GLU-SER-HIS-GLU-LYS-SER-LEU-GLY-GLU-ALA-ASP-LYS-ALA-ASP-VAL-ASP-VAL-LEU-THR-LYS-ALA-LYS-SER-GLN-OH |
|
詳細(xì)
|
Tyr63] PTH (63-84), human |
TYR-GLU-LYS-SER-LEU-GLY-GLU-ALA-ASP-LYS-ALA-ASP-VAL-ASN-VAL-LEU-THR-LYS-ALA-LYS-SER-GLN |
|
詳細(xì)
|
Angiotensin II type 1 receptor (181-187), AT1, ATE. |
ALA-PHE-HIS-TYR-GLU-SER-GLN |
|
詳細(xì)
|
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28 |
BIOTIN-SER-ALA-ASN-SER-ASN-PRO-ALA-LEU-ALA-PRO-ARG-GLU-ARG-LYS-ALA-GLY-CYS-LYS-ASN-PHE-PHE-D-TRP-LYS-THR-TYR-THR-SER-CYS (DISULFIDE BRIDGE:CYS17-CYS28) |
|
詳細(xì)
|
TNF-α(71-82), human |
H-SER-PRO-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-OH |
|
詳細(xì)
|
Saposin C18 |
VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU |
|
詳細(xì)
|
Protein Kinase C Substrate, Glycogen Synthase (1-8) |
PRO-LEU-SER-ARG-THR-LEU-SER-VAL-ALA-ALA-LYS-LYS-NH2 |
|
詳細(xì)
|
CC Chemokine Receptor 3 Fragment II, amide |
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS-NH2 |
|
詳細(xì)
|